Lack of adverse pharmacodynamic drug interactions with rivastigmine and twenty-two classes of medications
Authors:
- 1 March 2000
- journal article
- research article
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 15 (3) , 242-247
Abstract
Alzheimer's disease (AD) is often associated with multiple comorbidities and subsequent polypharmacy. Treatment of AD with acetylcholinesterase (AChE) inhibitors can carry a risk of drug interaction with multiple medications often prescribed for other co‐existing illnesses. Rivastigmine is an AChE inhibitor that is enzymatically cleaved by AChE, minimally metabolized by cytochrome P450 enzymes, has low protein binding, has a short plasma half‐life, and a relatively short duration of action. Such properties make it ideal for use in this patient population. A pharmacodynamic analysis of rivastigmine administered concomitantly with other medications (22 different therapeutic classes) did not reveal any significant pattern of increase in adverse events that would indicate a drug interaction. In summary, rivastigmine was well tolerated and safely administered to a population receiving multiple medications for ‘real‐world’ comorbidities. Copyright © 2000 John Wiley & Sons, Ltd.Keywords
This publication has 10 references indexed in Scilit:
- Clinical pharmacology of rivastigmine: a new-generation acetylcholinesterase inhibitor for the treatment of alzheimer's diseaseClinical Therapeutics, 1998
- Donepezil Improves Cognition and Global Function in Alzheimer DiseaseA 15-Week, Double-blind, Placebo-Controlled StudyArchives of internal medicine (1960), 1998
- A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's diseaseNeurology, 1998
- RivastigmineDrugs & Aging, 1998
- Safety/tolerability trial of SDZ ENA 713 in patients with probable Alzheimer's diseaseLife Sciences, 1996
- Hepatotoxic Effects of Tacrine Administration in Patients With Alzheimer's DiseaseJAMA, 1994
- A Double-Blind, Placebo-Controlled Multicenter Study of Tacrine for Alzheimer's DiseaseNew England Journal of Medicine, 1992
- Medication Use Characteristics in the Elderly: The Iowa 65 + Rural Health StudyJournal of the American Geriatrics Society, 1987
- Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal ForebrainScience, 1982
- NEUROTRANSMITTER-RELATED ENZYMES AND INDICES OF HYPOXIA IN SENILE DEMENTIA AND OTHER ABIOTROPHIESBrain, 1976